Filing Details
- Accession Number:
- 0001225208-15-021347
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-11-24 13:00:09
- Reporting Period:
- 2015-11-20
- Filing Date:
- 2015-11-24
- Accepted Time:
- 2015-11-24 13:00:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
200406 | Johnson & Johnson | JNJ | Pharmaceutical Preparations (2834) | 221024240 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1537710 | H Michael Ullmann | One Johnson &Amp; Johnson Plaza New Brunswick NJ 08933 | Vp, General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-11-20 | 22,626 | $58.34 | 94,878 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-11-20 | 17,650 | $102.47 | 77,228 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Options (Right to Buy) | Disposition | 2015-11-20 | 22,626 | $0.00 | 22,626 | $58.34 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2009-02-14 | 2016-02-12 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 170 | Indirect | By 401k |
Common Stock | 1,287 | Indirect | By ESOP |
Footnotes
- This transaction was executed in multiple trades at prices ranging from 102.467 to 102.470. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (10/30/2015).
- Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (10/30/2015).